De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials-Reference-Cited by-同舟云学术

De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials

Published:2024-09 Issue:10456 Volume:404 Page:937-948
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Valgimigli Marco,Hong Sung-Jin,Gragnano Felice,Chalkou Konstantina,Franzone Anna,da Costa Bruno R,Baber Usman,Kim Byeong-Keuk,Jang Yangsoo,Chen Shao-Liang,Stone Gregg W,Hahn Joo-Yong,Windecker Stephan,Gibson Michael C,Song Young Bin,Ge Zhen,Vranckx Pascal,Mehta Shamir,Gwon Hyeon-Cheol,Lopes Renato D,Dangas George D,McFadden Eùgene P,Angiolillo Dominick J,Leonardi Sergio,Heg Dik,Calabrò Paolo,Jüni Peter,Mehran Roxana,Hong Myeong-Ki

Funder

Istituto Cardiocentro Ticino

Ente Ospedaliero Cantonale

Publisher

Elsevier BV

Reference29 articles.

1. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

2. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery

3. Ticagrelor alone versus dual antiplatelet therapy from 1 month after drug-eluting coronary stenting;Franzone;J Am Coll Cardiol,2019

4. Effect of P2Y12 inhibitor monotherapy vs dual antiplatelet therapy on cardiovascular events in patients undergoing percutaneous coronary intervention: the SMART-CHOICE randomized clinical trial;Hahn;JAMA,2019

5. Effect of ticagrelor monotherapy vs ticagrelor with aspirin on major bleeding and cardiovascular events in patients with acute coronary syndrome: the TICO randomized clinical trial;Kim;JAMA,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is this the conclusive evidence for ticagrelor monotherapy in acute coronary syndromes?;The Lancet;2024-09